PMID- 23972133 OWN - NLM STAT- MEDLINE DCOM- 20150625 LR - 20191027 IS - 1481-8043 (Electronic) IS - 1481-8035 (Linking) VI - 15 IP - 5 DP - 2013 Sep TI - Does the sedation regimen affect adverse events during procedural sedation and analgesia in injection drug users? PG - 279-88 AB - OBJECTIVES: Injection drug users (IDUs) often undergo procedural sedation and analgesia (PSA) as part of emergency department (ED) treatment. We compared adverse events (AEs) using a variety of sedation regimens. METHODS: This was a retrospective analysis of a PSA safety audit in two urban EDs. Consecutive self-reported IDUs were identified, and structured data describing comorbidities, vital signs, sedation regimens (propofol [P], propofol-fentanyl [PF], fentanyl-midazolam [FM], ketofol [1:1 ketamine:propofol, KF], and ketamine-propofol [KP]) and AEs were collected. The primary outcome was the proportion of patients in each sedation group having an AE; the secondary outcome was the proportion of patients having a cardiovascular or respiratory AE. RESULTS: Data were collected on 276 IDUs (78 P, 82 PF, 65 FM, 25 KF, and 26 KP), and 18 patients had AEs (6.5%, 95% CI 4.0-10.3). The AE rates were 0.0%, 8.5%, 9.2%, 12.0%, and 7.6%, respectively, with propofol having a significantly lower rate (Pearson coefficient 14.9, p = 0.007). The cardiovascular/respiratory AE rates were significantly different as well, with P, KP, and KF having the lowest rates (Pearson coefficient 13.3, p = 0.01). CONCLUSIONS: For IDU PSA, the overall AE rate was 6.5%, and propofol appeared to have a significantly lower rate. FAU - Xavier Scheuermeyer, Frank AU - Xavier Scheuermeyer F FAU - Andolfatto, Gary AU - Andolfatto G FAU - Qian, Hong AU - Qian H FAU - Grafstein, Eric AU - Grafstein E LA - eng PT - Journal Article PT - Multicenter Study PL - England TA - CJEM JT - CJEM JID - 100893237 SB - IM MH - Adult MH - Analgesia/*adverse effects MH - Conscious Sedation/*methods MH - *Drug Users MH - *Emergency Service, Hospital MH - Emergency Treatment/*methods MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Retrospective Studies MH - Risk Factors EDAT- 2013/08/27 06:00 MHDA- 2015/06/26 06:00 CRDT- 2013/08/27 06:00 PHST- 2013/08/27 06:00 [entrez] PHST- 2013/08/27 06:00 [pubmed] PHST- 2015/06/26 06:00 [medline] AID - 10.2310/8000.2013.130933 [doi] PST - ppublish SO - CJEM. 2013 Sep;15(5):279-88. doi: 10.2310/8000.2013.130933.